Literature DB >> 27102186

Chronic kidney disease from screening, detection, and awareness, to prevention.

Melody Sherwood1, Peter A McCullough2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27102186     DOI： 10.1016/S2214-109X(16)30049-3

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  5 in total

1.  Sleep Quality and Sleep Duration with CKD are Associated with Progression to ESKD.

Authors:  Ryohei Yamamoto; Maki Shinzawa; Yoshitaka Isaka; Etsuko Yamakoshi; Enyu Imai; Yasuo Ohashi; Akira Hishida
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-15       Impact factor: 8.237

Review 2.  Value of SGLT-2 inhibitors in the treatment of chronic kidney disease : Clinical and practical implications.

Authors:  Marcus Säemann; Daniel Cejka; Sabine Schmaldienst; Alexander R Rosenkranz; Gert Mayer
Journal:  Wien Klin Wochenschr       Date:  2022-10-17       Impact factor: 2.275

3.  Comparison between the Beta-2 Microglobulin-Based Equation and the CKD-EPI Equation for Estimating GFR in CKD Patients in China: ES-CKD Study.

Authors:  Lili Yue; Binbin Pan; Xiumin Shi; Xin Du
Journal:  Kidney Dis (Basel)       Date:  2020-02-25

4.  Development and application of a chronic kidney disease-specific health literacy, knowledge and disease awareness assessment tool for patients with chronic kidney disease in Taiwan.

Authors:  Chung-Jen Wei; Chung-Liang Shih; Yu-Juei Hsu; Yin-Cheng Chen; Jue-Zong Yeh; Jia-Hui Shih; Chiung-Hsuan Chiu
Journal:  BMJ Open       Date:  2021-10-11       Impact factor: 2.692

5.  Effect of body mass index on the association between alcohol consumption and the development of chronic kidney disease.

Authors:  Yusaku Hashimoto; Takahiro Imaizumi; Sawako Kato; Yoshinari Yasuda; Takuji Ishimoto; Hiroaki Kawashiri; Akihiro Hori; Shoichi Maruyama
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.